IL190520A0 - Compositions and methods for treatment of autoimmune - Google Patents

Compositions and methods for treatment of autoimmune

Info

Publication number
IL190520A0
IL190520A0 IL190520A IL19052008A IL190520A0 IL 190520 A0 IL190520 A0 IL 190520A0 IL 190520 A IL190520 A IL 190520A IL 19052008 A IL19052008 A IL 19052008A IL 190520 A0 IL190520 A0 IL 190520A0
Authority
IL
Israel
Prior art keywords
autoimmune
compositions
treatment
methods
Prior art date
Application number
IL190520A
Other languages
English (en)
Original Assignee
Bayhill Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayhill Therapeutics Inc filed Critical Bayhill Therapeutics Inc
Publication of IL190520A0 publication Critical patent/IL190520A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0007—Nervous system antigens; Prions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL190520A 2005-10-05 2008-03-30 Compositions and methods for treatment of autoimmune IL190520A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72420305P 2005-10-05 2005-10-05
PCT/US2006/038776 WO2007044394A2 (en) 2005-10-05 2006-10-04 Compositions and methods for treatment of autoimmune disease

Publications (1)

Publication Number Publication Date
IL190520A0 true IL190520A0 (en) 2008-11-03

Family

ID=37943343

Family Applications (1)

Application Number Title Priority Date Filing Date
IL190520A IL190520A0 (en) 2005-10-05 2008-03-30 Compositions and methods for treatment of autoimmune

Country Status (9)

Country Link
US (1) US20100160415A1 (https=)
EP (1) EP1931390B1 (https=)
JP (1) JP2009511014A (https=)
CN (1) CN101365494A (https=)
AU (1) AU2006302477A1 (https=)
CA (1) CA2624615A1 (https=)
IL (1) IL190520A0 (https=)
NZ (1) NZ567150A (https=)
WO (1) WO2007044394A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1668105T3 (pl) * 2003-09-29 2019-03-29 Deb Ip Limited Kompozycje żelopodobne i pieniące o dużej zawartości alkoholu
DE102004062775A1 (de) 2004-12-21 2006-06-29 Stockhausen Gmbh Alkoholischer Pumpschaum
BRPI0608347A2 (pt) 2005-03-07 2009-12-08 Deb Worldwide Healthcare Inc composição alcoólica espumável, concentrado de composição, composição alcoólica desinfetante espumável, métodos para formar, produzir e dispensar uma espuma, dispensador não pressurizado, e, métodos para usar uma composição alcoólica de espuma para desinfecção pessoal e para produzir e aplicar a uma pele de indivìduo uma composição alcoólica de espuma desinfetante de pele
WO2010151420A1 (en) * 2009-06-05 2010-12-29 Bayhill Therapeutics, Inc. Compositions and methods for treatment of insulin-dependent diabetes mellitus
EP2525825A1 (en) * 2010-01-20 2012-11-28 Bayhill Therapeutics, Inc. Combination therapy to treat autoimmune diseases
EP2716756B1 (en) * 2011-05-25 2021-12-08 National University Corporation Okayama University Reic-expressing adenovirus vector for use in treating cancer
KR101466875B1 (ko) * 2012-05-11 2014-12-03 가톨릭대학교 산학협력단 항종양괴사인자 수용체 2를 발현하도록 설계된 미니서클 벡터를 이용한 자가면역질환 치료
KR101466874B1 (ko) * 2012-05-11 2014-12-03 가톨릭대학교 산학협력단 자가면역 질환의 예방과 치료를 위한 ｉｌ-６ 수용체에 대한 항체를 발현하는 미니서클
US20160287685A1 (en) 2013-11-22 2016-10-06 Amarna Holding B.V. Method for restoring immune tolerance in vivo
EP3090263A4 (en) * 2013-12-31 2017-08-23 Yeda Research and Development Co., Ltd. Methods for assaying immunological competence
US10545144B2 (en) 2013-12-31 2020-01-28 Yeda Research And Development Co., Ltd. Diagnosis of systemic lupus erythematosus using oligonucleotides antigens
CN106535926B (zh) * 2014-06-04 2022-02-01 戴尔米德医疗公司 用于基于抗原的疗法的新型组合物
US12605432B2 (en) 2014-06-04 2026-04-21 Diamyd Medical Ab Combinations for antigen based therapy
EP3265814B1 (en) 2015-03-01 2020-11-18 Immunarray Ltd. Diagnosis of systemic lupus erythematosus using protein, peptide and oligonucleotide antigens
WO2017222911A1 (en) * 2016-06-20 2017-12-28 The Board Of Trustees Of The Leland Stanford Junior University Circular rnas and their use in immunomodulation
CA3042321A1 (en) 2016-11-01 2018-05-11 Novo Nordisk A/S Tolerogenic dna vaccine
US20210277417A1 (en) * 2018-06-25 2021-09-09 Akouos, Inc. Methods of treating clrn1-associated hearing loss and/or vision loss
US11279745B2 (en) 2019-04-26 2022-03-22 Novo Nordisk A/S Tolerogenic DNA vaccine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274136B1 (en) * 1996-05-29 2001-08-14 University Of Southern California Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease
WO2000002591A1 (en) * 1998-07-09 2000-01-20 Merck & Co., Inc. Polynucleotide vaccine formulations
WO2000046147A2 (en) * 1999-02-03 2000-08-10 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles and methods of manufacture and use
US7030098B2 (en) * 1999-03-12 2006-04-18 The Board Of Trustees Of The Leland Stanford Junior University DNA vaccination for treatment of autoimmune disease
US6479474B2 (en) * 1999-07-08 2002-11-12 Wisconsin Alumni Research Foundation Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
EP1421104A4 (en) * 2001-08-02 2005-08-24 Trinity Biomedical Technology HUMANE ZONA PELLUCIDA PROTEINS AND METHOD FOR THEIR USE IN THE DIAGNOSIS OF MALE INFERENCE
CN101670119A (zh) * 2001-11-21 2010-03-17 利兰·斯坦福青年大学托管委员会 多核苷酸
WO2003082269A1 (en) * 2002-03-29 2003-10-09 The Board Of Trustees Of The Leland Stanford Junior University Use of statins and other immunomodulatory agents in the treatment of autoimmune disease
PT1685251E (pt) * 2003-10-10 2014-04-15 Powderject Vaccines Inc Construções de ácido nucleico

Also Published As

Publication number Publication date
EP1931390A4 (en) 2009-04-15
US20100160415A1 (en) 2010-06-24
WO2007044394A2 (en) 2007-04-19
CA2624615A1 (en) 2007-04-19
WO2007044394A3 (en) 2007-07-12
JP2009511014A (ja) 2009-03-19
CN101365494A (zh) 2009-02-11
EP1931390B1 (en) 2012-07-25
NZ567150A (en) 2011-12-22
AU2006302477A1 (en) 2007-04-19
EP1931390A2 (en) 2008-06-18

Similar Documents

Publication Publication Date Title
IL190520A0 (en) Compositions and methods for treatment of autoimmune
ZA200704677B (en) Compositions and methods for the treatment of autism
SI1791791T1 (sl) Postopki in sestavki za obdelavo vode
ZA200900388B (en) Compositions and methods for the treatment of mucositis
IL188237A0 (en) Compositions and methods for treatment of cycle-related symptoms
IL181896A0 (en) Methods and compositions for the treatment of hyperlipidemia
IL200766A0 (en) Compositions and methods for the prevention and treatment of autoimmune conditions
IL186963A0 (en) Methods and compositions for treating pain
SI2079760T1 (sl) Sestavki in metode za zdravljenje okužb
PT2101766T (pt) Composições e métodos de utilização de (r)-pramipexole
IL191072A0 (en) Therapeutic compositions and methods
IL197804A0 (en) Compositions for the trearment of hepatitis c and methods for using compositions for the treatment of hepatitis c
IL177849A0 (en) Methods and compositions for treatment of autoimmune diseases
PL2069467T3 (pl) Kompozycje wydzielające i sposoby stosowania
EP1991270A4 (en) COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF CACHEXIA
PL2101766T3 (pl) Kompozycje i sposoby stosowania (R)-pramipeksolu
IL186325A0 (en) Tizanidine compositions and methods of treatment using the compositions
EP1890712A4 (en) COMPOSITIONS AND METHODS FOR TREATING PAIN
IL187405A0 (en) Methods and compositions for the treatment of pain
IL196411A0 (en) Anti-cocaine compositions and treatment
EP1786265A4 (en) NEW COMPOSITIONS AND PROCESSING METHODS
ZA200703087B (en) Methods and compositions for the treatment of hyperlipidemia
EP1937075A4 (en) SYNERGIC COMPOSITION AND METHOD OF USE
IL180195A0 (en) Aequorin-containing compositions and methods of using same
EP1912630A4 (en) COMPOSITIONS AND METHODS FOR REDUCING POSTOPERATIVE PAIN